找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Progress in Cancer Immunotherapy; Shuren Zhang Book 2016 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sprin

[复制链接]
查看: 17080|回复: 35
发表于 2025-3-21 17:39:12 | 显示全部楼层 |阅读模式
书目名称Progress in Cancer Immunotherapy
编辑Shuren Zhang
视频video
概述Provides readers with recent progress in basic and clinical research of cancer immunotherapy.Covers hot topics in cancer immunotherapy, such as cancer vaccines, monoclonal antibodies and adoptive cell
丛书名称Advances in Experimental Medicine and Biology
图书封面Titlebook: Progress in Cancer Immunotherapy;  Shuren Zhang Book 2016 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sprin
描述.Thisbook provides readers an extensive overview of recent progress in basicand clinical research on cancer immunotherapy. Thanks to rapid advances inmolecular biology and immunology, it has become increasingly evident thatcancer growth is influenced by host immune responses. With the success of anumber of clinical trials, immunotherapy has become a promising treatmentmodality of cancer. This book covers five major topics, including monoclonalantibodies, biological response modifiers, cancer vaccines, adoptive cellulartherapy and oncolytic viruses. It also examines the combination of differentimmune strategies as well as the combination of immunotherapy with othertreatments to increase anti-tumor effects. Throughthecomprehensive discussion of the topic, the book sheds valuable new light on thetreatment of tumors..
出版日期Book 2016
关键词Antibody; Cancer immunotherapy; Cellular immunotherapy; Oncolytic virus; Vaccine; antibodies; vaccines
版次1
doihttps://doi.org/10.1007/978-94-017-7555-7
isbn_softcover978-94-024-1379-3
isbn_ebook978-94-017-7555-7Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature B.V. 201
The information of publication is updating

书目名称Progress in Cancer Immunotherapy影响因子(影响力)




书目名称Progress in Cancer Immunotherapy影响因子(影响力)学科排名




书目名称Progress in Cancer Immunotherapy网络公开度




书目名称Progress in Cancer Immunotherapy网络公开度学科排名




书目名称Progress in Cancer Immunotherapy被引频次




书目名称Progress in Cancer Immunotherapy被引频次学科排名




书目名称Progress in Cancer Immunotherapy年度引用




书目名称Progress in Cancer Immunotherapy年度引用学科排名




书目名称Progress in Cancer Immunotherapy读者反馈




书目名称Progress in Cancer Immunotherapy读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:10:40 | 显示全部楼层
第160338主题贴--第2楼 (沙发)
发表于 2025-3-22 01:07:38 | 显示全部楼层
板凳
发表于 2025-3-22 07:35:52 | 显示全部楼层
第4楼
发表于 2025-3-22 11:39:26 | 显示全部楼层
5楼
发表于 2025-3-22 16:55:27 | 显示全部楼层
6楼
发表于 2025-3-22 20:50:56 | 显示全部楼层
7楼
发表于 2025-3-22 23:18:46 | 显示全部楼层
8楼
发表于 2025-3-23 03:25:03 | 显示全部楼层
9楼
发表于 2025-3-23 08:10:17 | 显示全部楼层
10楼
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-29 06:37
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表